Vocxi Health is an early-detection diagnostic start-up born from a global medical device leader and a world-class research university. With its expert team of scientific, medical-device and diagnostic leaders who have dedicated their lives to transforming the patient journey, Vocxi Health has the knowledge, drive and track record to bring the most accessible and accurate point-of-care breath diagnostic to the healthcare market, reshaping the patient journey one person, one minute at a time.
After years of research and development of the MyBreathPrint® technology and system, the Vocxi Health team is integrating with a global network of development, regulatory, quality and manufacturing partners to bring MyBreathPrint to millions of people in hospitals, clinics and homes worldwide.
Vocxi Health has initially developed MyBreathPrint to detect lung cancer because it has the highest mortality rate of any cancer. This devastating distinction is primarily due to the challenges of detecting and diagnosing lung cancer in its early stages. However, with one hardware design, MyBreathPrint is scalable and, through its machine learning platform, quickly adaptable and customizable to detect a wide variety of diseases, ailments and uses.
Vocxi Health’s simple-to-use MyBreathPrint diagnostic system leverages machine learning and mobile connectivity to improve access to early disease detection and quality diagnostic care.
At the intersection of chemistry, nanotechnology and machine learning, MyBreathPrint measures thousands of volatile organic compound (VOC) patterns to create a BreathPrint® — as unique as a fingerprint — of a patient’s health status.
After only one minute of breathing, a clinician will know within seconds a patient’s disease and/or health status. MyBreathPrint works at a metabolomic level, so even stage-one cancer and the presence of infectious diseases are detectable.
Born from a collaboration between a global medical device leader and a world-class research university, MyBreathPrint has been developed for the past decade by a cross-functional, cross-discipline team driven to make late-stage cancer a thing of the past.
Explore the broad applications of MyBreathPrint, an early disease detection system as noninvasive as one minute of breathing.
Born from a global medical device leader and a world-class research university, Vocxi Health is the innovator of MyBreathPrint®, the noninvasive, early disease detection system that delivers accurate results with just one minute of breathing: no needles, no radiation, no waiting.
© 2024 Vocxi Health. All Rights Reserved.
Website created by Red Mood Marketing
in collaboration with Blue Tricycle.
Sign up for More Information